[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100479220":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":32,"centralContacts":40,"locations":50,"responsibleParty":81,"collaborators":31,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":85,"sex":91,"minAge":92,"maxAge":31,"enrollmentInfo":93,"targetDuration":31,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":53,"whyStopped":31,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Centre Hospitalier Intercommunal Robert Ballanger","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ORAL impact group","EXPERIMENTAL","This group of patients will receive a 7-days course of IMPACT ORAL 20 days before the surgery",[13],"Dietary Supplement: ORAL IMPACT treatment",{"label":15,"type":6,"description":16,"interventionNames":17},"control","a retrospective cohort of patients operated between 2016 and 2019 by nephrectomy cystectomy and laparotomy who did not receive oral impact",[18],"Other: control",[20,28],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","ORAL IMPACT treatment","the group of patients will be received a 7-days course of ORAL IMPACT",[9],[26,27],"Monitoring of postoperative albumin on days 1, 3, 5, 7, and 10","correction of postoperative hypoalbuminemia (\u003C35 g\u002FL) by albumine 20% administration in case of postoperative complications",{"type":6,"name":15,"description":29,"armGroupLabels":30,"otherNames":31},"no intervention",[15],null,[33,37],{"name":34,"affiliation":35,"role":36},"Serge NDOKO, MD","Robert ballanger","PRINCIPAL_INVESTIGATOR",{"name":38,"affiliation":39,"role":36},"MAtthieu CAMBY, MD","Centre Hospitalier Intercommunal André Grégoire",[41,47],{"name":42,"role":43,"phone":44,"phoneExt":45,"email":46},"Serge Ndoko, MD","CONTACT","01.49.36.70.41","+33","serge.ndoko@ght-gpne.fr",{"name":48,"role":43,"phone":44,"phoneExt":45,"email":49},"Sabrina Lassouani, MD","sabrina.lassouani-amara@ght-gpne.fr",[51,67],{"facility":52,"status":53,"city":54,"state":31,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"CHI Robert Ballanger","RECRUITING","Aulnay-sous-Bois","93600","France","FR",{"type":59,"coordinates":60},"Point",[61,62],2.49402,48.93814,{"lat":62,"lon":61},[65],{"name":34,"role":43,"phone":66,"phoneExt":31,"email":46},"01 49 36 71 23",{"facility":68,"status":53,"city":69,"state":31,"zip":70,"country":56,"countryCode":57,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"CHI André Grégoire","Montreuil","93100",{"type":59,"coordinates":72},[73,74],2.44322,48.86415,{"lat":74,"lon":73},[77],{"name":78,"role":43,"phone":79,"phoneExt":31,"email":80},"Matthieu CAMBY, MD","0149203040","matthieu.camby@ght-gpne.fr",{"type":82,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR","100479220","influence-of-preoperative-immunomodulation-by-oral-impact-on-postoperative-complications-following-cystectomies--nephrectomies-100479220",false,"NCT05520151","Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies","Influence of Preoperative Immunomodulation by Oral Impact® on Postoperative Complications Following Cystectomies and Nephrectomies","IMPACTURO","Inclusion Criteria:\n\n* 18 years of age and older\n* Scheduled major urological surgery: scheduled: cystectomy, nephrectomy, other laparotomies.\n* Having expressed their free and informed consent.\n* Affiliated to a social security scheme\n\nExclusion Criteria:\n\n* Immune deficiency.\n\n  * HIV infection.\n  * Curative surgery for chronic urinary tract infection.\n  * Urgent surgery.\n  * Inability to take oral impact 7 days before surgery.\n  * Unstable psychiatric state.\n  * Infection with COVID 19 during postoperative stay.","ALL","18 Years",{"count":94,"type":95},214,"ESTIMATED","INTERVENTIONAL",[98],"NA","any studies have shown the benefit of perioperative Oral Impact immunomodulation in gastrointestinal, ENT, gynecological and cardiac surgery. Studies in major Urological surgery are rare and not very contributory. The expected benefit is a reduction in postoperative complications and the average length of stay.",[101],"Urological Manifestations",[103,104,105,106],"cystectomy,","nephrectomy,","laparotomies","reduction of postoperative complications","2024-07-11",{"date":109,"type":110},"2024-07-15","ACTUAL",{"date":112,"type":110},"2022-11-30",{"date":114,"type":95},"2025-06",{"name":5,"class":6},2]